Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Current Assets (2016 - 2023)

Rapid Therapeutic Science Laboratories' Current Assets history spans 8 years, with the latest figure at $317882.0 for Q2 2023.

  • For Q2 2023, Current Assets fell 10.23% year-over-year to $317882.0; the TTM value through Jun 2023 reached $317882.0, down 10.23%, while the annual FY2022 figure was $233193.0, 44.37% down from the prior year.
  • Current Assets for Q2 2023 was $317882.0 at Rapid Therapeutic Science Laboratories, up from $250765.0 in the prior quarter.
  • Across five years, Current Assets topped out at $1.2 million in Q3 2021 and bottomed at $1334.0 in Q1 2019.
  • The 5-year median for Current Assets is $246253.5 (2020), against an average of $305422.9.
  • The largest annual shift saw Current Assets plummeted 94.07% in 2019 before it surged 13973.65% in 2020.
  • A 5-year view of Current Assets shows it stood at $125132.0 in 2019, then surged by 448.18% to $685948.0 in 2020, then plummeted by 38.89% to $419162.0 in 2021, then tumbled by 44.37% to $233193.0 in 2022, then skyrocketed by 36.32% to $317882.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Current Assets are $317882.0 (Q2 2023), $250765.0 (Q1 2023), and $233193.0 (Q4 2022).